Skip to content

A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient

A Pilot Study for PK/PD Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01145274
Acronym
Allopurinol
Enrollment
80
Registered
2010-06-16
Start date
2010-06-30
Completion date
2013-02-28
Last updated
2011-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

allopurinol, chronic kidney diseae

Brief summary

To know the blood level of allopurinol in chronic kidney disease (CKD) patient.

Detailed description

After the result of this pilot study, we can prescribe the optimal dose of allopurinol in CKD patient.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* from 18yrs to 80yrs , man and women * the patient who are taking allopurinol * On screening, the patient shows that the level of protein/creatinine ratio is over 3.0 * On screening, the patient shows that MDRD GFR \>= 30 ml/min and \<= 60 ml/min * the patient sign on the concent form

Exclusion criteria

* the patient have experience to take medication that have an effect on renal function * the patient have experience to take cyclosporin within 3month * At least, the average level of two separate blood pressure ( 2min interval ) shows that SBP \<= 100 mmHg or \>=160 mmHg and DBP \<=60 mmHg \>=100 mmHg, or Heart rate \< 40 beats/min or \> 90 beats/min * uncontrolled hypertension * pregnancy or anticipate pregnancy with 6 month * hypersensitivity to allopurinol * acute hepatitis or the level of AST or ALT is over 2times of normal range or the level of bilirubin is over 2.0 mg/dL * serum albumin \< 3.5 mg/dL or \> 5mg/dL * urinary retension, prostatic hyperplasia * the patient show gout attack on taking allopurinol * the patient who have gastro-intestinal disease ( ex, crohn's disease, acute or chronic pancreatitis, ulcer )or who have the surgical history of gastrointestine. * the patient who should take azathioprine, mercaptopurine, cyclophosphamide, Losartan, benzbromarone,fenofibrate,furosemide ,probenecid * the patient who had taken part in the other study within 3months * the patient who had gotten blood transfusion * pregnant, breast feeding

Countries

South Korea

Contacts

Primary ContactHo Seok Koo, Dr
hoseok.koo@gmail.com82-2-2072-2496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026